Six X-linked agammaglobulinemia-causing missense mutations in the Src homology 2 domain of Bruton's tyrosine kinase: Phosphotyrosine-binding and circular dichroism analysis

Journal of Immunology

Volumn 164, Issue 8, 2000, Pages 4170-4177

  Mattsson, Pekka T ^a,b   Lappalainen, Ilkka ^c,d   Bäckesjö, Carl Magnus ^b   Brockmann, Eeva ^a   Laurén, Susanna ^a   Vihinen, Mauno ^d   Smith, C I Edvard ^b  

^a UNIVERSITY OF TURKU   (Finland)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c UNIVERSITY OF HELSINKI   (Finland)

^d UNIVERSITY OF TAMPERE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOTYROSINE; PROTEIN TYROSINE KINASE;

AMINO ACID SUBSTITUTION; ARTICLE; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; GENE DISRUPTION; GENE FUNCTION; GENE STRUCTURE; GENETIC CONSERVATION; MISSENSE MUTATION; PRIORITY JOURNAL; PROTEIN BINDING; SEQUENCE HOMOLOGY; X LINKED AGAMMAGLOBULINEMIA;

EID: 0034655206     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.164.8.4170     Document Type: Article

References (83)

1. Smith, C. I. E., K. B. Islam, I. Vořechovský, O. Olerup, E. Wallin, H. Rabbani, B. Baskin, and L. Hammarström. 1994. X-linked agammaglobulinemia and other immunoglobulin deficiencies. Immunol. Rev. 138:159.
2. Smith, C. I. E., B. Baskin, P. Humire-Greiff, J. N. Zhou, P. G. Olsson, H. S. Maniar, P. Kjellén, J. D. Lambris, B. Christensson, L. Hammarström, D. Bentley, D. Vetrie, K. B. Islam, I. Vořechovský, and P. Sideras. 1994. Expression of Bruton's agammaglobulinemia tyrosine kinase gene, BTK, is selectively down-regulated in T lymphocytes and plasma cells. J. Immunol. 112:557.
3. De Weers, M., M. C. Verschuren, M. E. Kraakman, R. G. Mensink, R. K. Schuurman, J. J. van Dongen, and R. W. Hendriks. 1993. The Bruton's tyrosine kinase gene is expressed throughout B cell differentiation, from early precursor B cell stages preceding immunoglobulin gene rearrangement up to mature B cell stages. Eur. J. Immunol. 12:3109.
4. Hendriks, R. W., M. F. de Bruijn, A. Maas, G. M. Dingjan, A. Karis, and F. Grosveld. 1996. Inactivation of Btk by insertion of lacZ reveals defects in B cell development only past the pre-B cell stage. EMBO J. 15:4862.
5. Vihinen, M., L. Nilsson, and C. I. E. Smith. 1994. Tec homology (TH) adjacent to the PH domain. FEBS Lett. 350:263.
6. Satterthwaite, A. B., Z. Li, and O. N. Witte. 1998. Btk function in B cell development and response. Semin. Immunol. 10:309.
7. Mattsson, P. T., M. Vihinen, and C. I. E. Smith. 1996. X-linked agammaglobulinemia (XLA): a genetic tyrosine kinase (Btk) disease. BioEssays 18:825.
8. Sideras, P., and C. I. E. Smith. 1995. Molecular and cellular aspects of X-linked agammaglobulinemia. Adv. Immunol. 59:135.
9. Smith, C. I. E., and L. D. Notarangelo. 1997. Molecular basis for X-linked immunodeficiencies. Adv. Genet. 35:57.
10. Lederman, H. M., and J. A. Winkelstein. 1985. X-linked agammaglobulinemia: an analysis of 96 patients. Medicine 64:145.
11. Ochs, H. D., and C. I. E. Smith. 1996. X-linked agammaglobulinemia: a clinical and molecular analysis. Medicine 75:287.
12. Campana, D., J. Farrant, N. Inamdar, A. D. Webster, and G. Janossy. 1990. Phenotypic features and proliferative activity of B cell progenitors in X-linked agammaglobulinemia. J. Immunol. 145:1675.
13. Pearl, E. R., L. B. Vogler, A. J. Okos, W. M. Crist, A. R. Lawton III, and M. D. Cooper. 1978. B lymphocyte precursors in human bone marrow: an analysis of normal individuals and patients with antibody-deficiency states. J. Immunol. 120:1169.
14. Vihinen, M., M. D. Cooper, G. de Saint Basile, A. Fischer, R. A. Good, R. W. Hendriks, C. Kinnon, S. P. Kwan, G. W. Litman, L. D. Notarangelo, et al. 1995. BTKbase: a database of XLA-causing mutations: International Study Group. Immunol. Today 16:460.
15. Vihinen, M., T. Iwata, C. Kinnon, S. P. Kwan, H. D. Ochs, I. Vořechovský, and C. I. E. Smith. 1996. BTKbase, mutation database for X-linked agammaglobulinemia (XLA). Nucleic Acids Res. 24:160.
16. Vihinen, M., B. H. Belohradsky, R. N. Haire, E. Holinski-Feder, S. P. Kwan, I. Lappalainen, H. Lehvaslaiho, T. Lester, A. Meindl, H. D. Ochs, et al. 1997. BTKbase, mutation database for X-linked agammaglobulinemia. Nucleic Acids Res. 25:166.
17. Vihinen, M., O. Brandau, L. J. Branden, S. P. Kwan, I. Lappalainen, T. Lester, J. G. Noordzij, H. D. Ochs, J. Ollila, S. M. Pienaar, et al. 1998. BTKbase, mutation database for X-linked agammaglobulinemia (XLA). Nucleic Acids Res. 26:242.
18. Vihinen, M., S. P. Kwan, T. Lester, H. D. Ochs, I. Resnick, J. Väliaho, M. E. Conley, and C. I .E. Smith. 1999. Mutations of the human BTK gene coding for Bruton tyrosine kinase in X-linked agammaglobulinemia. Hum. Mutat. 13:280.
19. Sadowski, I., J. C. Stone, and T. Pawson. 1986. A noncatalytic domain conserved among cytoplasmic protein-tyrosine kinases modifies the kinase function and transforming activity of Fujinami sarcoma virus P130gag-fps. Mol. Cell. Biol. 6:4396.
20. Pawson, T. 1994. Introduction: protein kinases. FASEB J. 8:1112.
21. Pawson, T. 1995. Protein modules and signalling networks. Nature 373:573.
22. Sawyer, T. K. 1998. Src homology-2 domains: structure, mechanisms, and drug discovery. Biopolymers 47:243.
23. Ladbury, J. E., M. A. Lemmon, M. Zhou, J. Green, M. C. Botfield, and J. Schlessinger. 1995. Measurement of the binding of tyrosyl phosphopeptides to SH2 domains: a reappraisal. Proc. Natl. Acad. Sci. USA 92:3199.
24. Charifson, P. S., L. M. Shewchuk, W. Rocque, C. W. Hummel, S. R. Jordan, C. Mohr, G. J. Pacofsky, M. R. Peel, M. Rodriguez, G. G. Sternbach, and T. G. Consler. 1997. Peptide ligands of pp60(c-src) SH2 domains: a thermodynamic and structural study. Biochemistry 36:6283.
25. Pawson, T., and J. Schlessinger. 1993. SH2 and SH3 domains. Curr. Biol. 3:434.
26. Songyang, Z., S. E. Shoelson, M. Chaudhuri, G. Gish, T. Pawson, W. G. Haser, F. King, T. Roberts, S. Ratnofsky, R. J. Lechleider, el al. 1993. SH2 domains recognize specific phosphopeptide sequences. Cell 72:767.
27. Songyang, Z., S. E. Shoelson, J. McGlade, P. Olivier, T. Pawson, X. R. Bustelo, M. Barracid, H. Sabe, H. Hanafusa, T. Yi, et al. 1994. Specific motifs recognized by the SH2 domains of Csk. 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav. Mol. Cell. Biol. 14:2777.
28. Réty, S., K. Fütterer, R. A. Grucza, C. M. Munoz, W. A. Frazier, and G. Waksman. 1996. pH-Dependent self-association of the Src homology 2 (SH2) domain of the Src homologous and collagen-like (SHC) protein. Protein Sci. 5:405.
29. Thornton, K. H., T. Müller, P. McConnell, G. Zhu, A. R. Saltiel, and V. Thanabal. 1996. Nuclear magnetic resonance solution structure of the growth factor receptor-bound protein 2 Src homology 2 domain. Biochemistry 35:11852.
30. Braverman, L. E., and L. A. Quilliam. 1999. Identification of Grb4/Nckβ, a Src homology 2 and 3 domain-containing adapter protein having similar binding and biological properties to Nck. J. Biol. Chem. 274:5542.
31. Liu, S. K., N. Fang, G. A. Koretzky, and C. J. McGlade. 1999. The hematopoietic-specific adaptor protein gads functions in T-cell signaling via interactions with the SLP-76 and LAT adaptors. Curr. Biol. 9:67.
32. Waksman, G., D. Kominos, S. C. Robertson, N. Pant, D. Baltimore, R. B. Birge, D. Cowburn, H. Hanafusa, B. J. Mayer, M. Overduin, et al. 1992. Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides. Nature 358:646.
33. Siegal, G., B. Davis, S. M. Kristensen, A. Sankar, J. Linacre, R. C. Stein, G. Panayotou, M. D. Waterfield, and P. C. Driscoll. 1998. Solution structure of the C-terminal SH2 domain of the p85α regulatory subunit of phosphoinositide 3-kinase. J. Mol. Biol. 276:461.
34. Songyang, Z., G. Gish, G. Mbamalu, T. Pawson, and L. C. Cantley. 1995. A single point mutation switches the specificity of group III Src homology (SH) 2 domains to that of group 1 SH2 domains. J. Biol. Chem. 270:26029.
35. Rameh, L. E., C. S. Chen, and L. C. Cantley. 1995. Phosphatidylinositol (3,4,5)P3 interacts with SH2 domains and modulates PI 3-kinase association with tyrosine-phosphorylated proteins. Cell 83:821.
36. Surdo, P. L., M. J. Bottomley, A. Arcaro, G. Siegal, G. Panayotou, A. Sankar, P. R. Gaffney, A. M. Riley, B. V. Potter, M. D. Waterfield, and P. C. Driscoll. 1999. Structural and biochemical evaluation of the interaction of the phosphatidylinositol 3-kinase p85α src homology 2 domains with phosphoinositides and inositol polyphosphates. J. Biol. Chem. 274:15678.
37. Vetrie, D., I. Vorechovský, P. Sideras, J. Holland, A. Davies, F. Flinter, L. Hammarstrom, C. Kinnon, R. Levinsky, M. Bobrow, et al. 1993. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 361:226.
38. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: A Laboratory Manual, 2nd Ed. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
39. Peränen, J., M. Rikkonen, M. Hyvönen, and L. Kääriäinen. 1996. T7 vectors with modified T71ac promoter for expression of proteins in Escherichia coli. Anal. Biochem. 236:371.
40. Ho, S. N., H. D. Hunt, R. M. Horton, J. K. Pullen, and L. R. Pease. 1989. Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51.
41. Studier, F. W., A. H. Rosenberg, J. J. Dunn, and J. W. Dubendorff. 1990. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol. 185:60.
42. Erpel, T., G. Superti-Furga, and S. A. Counneidge. 1995. Mutational analysis of the Src SH3 domain: the same residues of the ligand binding surface are important for intra-and intermolecular interactions. EMBO J. 14:963.
43. Chen, C., and H. Okayama. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell Biol. 7:2745.
44. Chen, C., and H. Okayama. 1988. Calcium phosphate-mediated gene transfer: a highly efficient transfection system for stably transforming cells with plasmid DNA. BioTechniques 6:632.
45. Vořechovský, I., L. Luo, G. de Saint Basile, L. Hammarström, A. D. Webster, and C. I. E. Smith. 1995. Improved oligonucleotide primer set for molecular diagnosis of X-linked agammaglobulinemia: predominance of amino acid substitutions in the catalytic domain of Bruton's tyrosine kinase. Hum. Mol. Genet. 4:2403.
46. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:248.
47. Sundberg, L., and J. Porath. 1974. Preparation of adsorbents for biospecific affinity chromatography: attachment of group-containing ligands to insoluble polymers by means of bifunctional oxiranes. J. Chromatogr. 90:87.
48. Sreerama, N., and R. W. Woody. 1993. A self-consistent method for the analysis of protein secondary structure from circular dichroism. Anal. Biochem. 209:32.
49. Sreerama, N., and R. W. Woody. 1994. Poly(pro)II helices in globular proteins: identification and circular dichroic analysis. Biochemistry 33:10022.
50. Sreerama, N., and R. W. Woody. 1994. Protein secondary structure from circular dichroism spectroscopy: combining variable selection principle and cluster analysis with neural network, ridge regression and self-consistent methods. J. Mol. Biol. 242:497.
51. Provencher, S. W., and J. Glockner. 1981. Estimation of globular protein secondary structure from circular dichroism. Biochemistry 20:33.
52. Greenfield, N. J. 1996. Methods to estimate the conformation of proteins and polypeptides from circular dichroism data. Anal. Biochem. 235:1.
53. Vihinen, M., L. Nilsson, and C. I. E. Smith. 1994. Structural basis of SH2 domain mutations in X-linked agammaglobulinemia. Biochem. Biophys. Res. Commun. 205:1270.
54. Brooimans, R. A., A. J. van den Berg, G. T. Rijkers, L. A. Sanders, J. K. van Amstel, M. G. Tilanus, M. J. Grubben, and B. J. Zegers. 1997. Identification of novel Bruton's tyrosine kinase mutations in 10 unrelated subjects with X linked agammaglobulinaemia. J. Med. Genet. 34:484.
55. Creighton, T. E. 1993. Proteins: Structures and Molecular Properties, 2nd Ed. W. H. Freeman and Company, New York.
56. Futatani, T., T. Miyawaki, S. Tsukada, S. Hashimoto, T. Kunikata, S. Arai, M. Kurimoto, Y. Niida, H. Matsuoka, Y. Sakiyama, et al. 1998. Deficient expression of Bruton's tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection. Blood 91:595.
57. Saffran, D. C., O. Parolini, M. E. Fitch-Hilgenberg, D. J. Rawlings, D. E. Afar, O. N. Witte, and M. E. Conley. 1994. Brief report: a point mutation in the SH2 domain of Bruton's tyrosine kinase in atypical X-linked agammaglobulinemia. N. Engl. J. Med. 330:1488.
58. Guilloteau, J. P., N. Fromage, M. Ries-Kautt, S. Reboul, D. Bocquet, H. Dubois, D. Faucher, C. Colonna, A. Ducruix, and J. Becquart. 1996. Purification, stabilization, and crystallization of a modular protein: Grb2. Proteins 25:112.
59. Huyer, G., and C. Ramachandran. 1998. The specificity of the N-terminal SH2 domain of SHP-2 is modified by a single point mutation. Biochemistry 37:2741.
60. Mizuguchi, K., C. M. Deane, T. L. Blundell, and J. P. Overington. 1998. HOM-STRAD: a database of protein structure alignments for homologous families. Protein Sci. 7:2469.
61. Barker, W C., J. S. Garavelli, P. B. McGarvey. C. R Marzec, B. C. Orcutt, G. Y. Srinivasarao, L. S. Yeh, R. S. Ledley, H. W. Mewes, F. Pfeiffer, et al. 1999. The PIR-international protein sequence database. Nucleic Acids Res. 27:39.
62. lck. Nature 362:87.
63. Vořechovský, I., L. Luo, J. M. Hertz, S. S. Froland, T. Klemola, M. Fiorini, I. Quinti, R. Paganelli, H. Ozsahin, L. Hammarström, et al. 1997. Mutation pattern in the Bruton's tyrosine kinase gene in 26 unrelated patients with X-linked agammaglobulinemia. Hum. Mutat. 9:418.
64. Bradley, L. A., A. K. Sweatman, R. C. Lovering, A. M. Jones, G. Morgan, R. J. Levinsky, and C. Kinnon. 1994. Mutation detection in the X-linked agammaglobulinemia gene, BTK, using single strand conformation polymorphism analysis. Hum. Mol. Genet. 3:79.
65. Marengere, L. E. M., and T. Pawson. 1992. Identification of residues in GTPase-activating protein Src homology 2 domains that control binding to tyrosine phosphorylated growth factor receptors and p62. J. Biol. Chem. 267:22779.
66. Mayer, B. J., P. K. Jackson, R. A. Van Etten, and D. Baltimore. 1992. Point mutations in the abl SH2 domain coordinately impair phosphotyrosine binding in vitro and transforming activity in vivo. Mol. Cell. Biol. 12:609.
67. Superti-Furga, G., S. Fumagalli, M. Koegl, S. A. Courtneidge, and G. Draetta. 1993. Csk inhibition of c-Src activity requires both the SH2 and SH3 domains of Src. EMBO J. 12:2625.
68. Gonfloni, S., J. C. Williams, K. Hattula, A. Weijland, R. K. Wierenga, and G. Superti-Furga. 1997. The role of the linker between the SH2 domain and catalytic domain in the regulation and function of Src. EMBO J. 16:7261.
69. Hashimoto, S., S. Tsukada, M. Matsushita, T. Miyawaki, Y. Niida, A. Yachie, S. Kobayashi, T. Iwata, H. Hayakawa, H. Matsuoka, et al. 1996. Identification of Bruton's tyrosine kinase (Btk) gene mutations and characterization of the derived proteins in 35 X-linked agammaglobulinemia families: a nationwide study of Btk deficiency in Japan. Blood 88:561.
70. Conley, M. E., D. Mathias, J. Treadaway, Y. Minegishi, and J. Rohrer. 1998. Mutations in btk in patients with presumed X-linked agammaglobulinemia. Am. J. Hum. Genet. 62:1034.
71. 2+ following B-cell receptor activation. EMBO J. 17:1973.
72. Rigley, K. P., M. M. Harnett, R. J. Phillips, and G. G. Klaus. 1989. Analysis of signaling via surface immunoglobulin receptors on B cells from CBA/N mice. Eur. J. Immunol. 19:2081.
73. Takata, M., and T. Kurosaki. 1996. A role for Bruton's tyrosine kinase in B cell antigen receptor-mediated activation of phospholipase C-γ2. J. Exp. Med. 184: 31.
74. Rawlings, D. J. 1999. Bruton's tyrosine kinase controls a sustained calcium signal essential for B lineage development and function. Clin. Immunol. 91:243.
75. Hashimoto, S., A. Iwamatsu, M. Ishiai, K. Okawa, T. Yamadori, M. Matsushita, Y. Baba, T. Kishimoto, T. Kurosaki and S. Tsukada. 1999. Identification of the SH2 domain binding protein of Bruton's tyrosine kinase as BLNK-functional significance of btk-SH2 domain in B-cell antigen receptor-coupled calcium signaling. Blood 94:2357.
76. Berridge, M. J. 1993. Inositol trisphosphate and calcium signalling. Nature 361:315.
77. Vassilev, A., Z. Ozer, C. Navara, S. Mahajan, and F. M. Uckun. 1999. Bruton's tyrosine kinase as an inhibitor of the Fas/CD95 death-inducing signaling complex. J. Biol. Chem. 274:1646.
78. Sicheri, F., and J. Kuriyan. 1997. Structures of Src-family tyrosine kinases. Curr. Opin. Struct. Biol. 7:777.
79. Xu, W., A. Doshi, M. Lei, M. J. Eck, and S. C. Harrison. 1999. Crystal structures of c-Src reveal features of its autoinhibitory mechanism. Mol. Cell 3:629.
80. Schindler, T., F. Sicheri, A. Pico, A. Gazit, A. Levitzki, and J. Kuriyan. 1999. Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor. Mol. Cell 3:639.
81. Sicheri, F., I. Moarefi, and J. Kuriyan. 1997. Crystal structure of the Src family tyrosine kinase Hck. Nature 385:602.
82. Xu, W., S. C. Harrison, and M. J. Eck. 1997. Three-dimensional structure of the tyrosine kinase c-Src. Nature 385:595.
83. Williams, J. C., A. Weijland, S. Gonfloni, A. Thompson, S. A. Courtneidge, G. Superti-Furga, and R. K. Wierenga. 1997. The 2.35 Å crystal structure of the inactivated form of chicken Src: a dynamic molecule with multiple regulatory interactions. J. Mol. Biol. 274:757.